NetMetaEasy: enabling rapid and user‐friendly network meta‐analysis (NMA) for comparative effectiveness research
British Journal of Pharmacology · 2026-05 · 183 (9) · 1814-1823
DOI: 10.1111/bph.70391 ↗At a glance
Journal article in British Journal of Pharmacology, published online on 2026-02-23. Written by János Tibor Fekete and 2 co-authors. Institution: Department of Bioinformatics, Semmelweis University, Budapest, Hungary. Major MEDLINE topics: Comparative Effectiveness Research, Software, Network Meta-Analysis as Topic. Cited 14 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background and Purpose Network meta‐analysis (NMA) enables the simultaneous comparison of multiple treatments by combining direct and indirect evidence across a network of studies. While its application is rapidly expanding in pharmacological research and clinical guideline development, performing NMA typically requires advanced statistical knowledge and access to specialized software, limiting its broader adoption. Here, we present NetMetaEasy, a user‐friendly, web‐based platform that allows rapid execution and visualization of network meta‐analyses from standard input formats, with minimal technical expertise required. Experimental Approach NetMetaEasy is an R/Shiny‐based platform supporting binary, continuous and summary‐effect data (e.g. odds ratios, hazard ratios). It offers frequentist and Bayesian network meta‐analysis with P ‐score and SUCRA‐based treatment ranking. It generates standard outputs including network diagrams, forest plots, netleague tables, inconsistency assessments and funnel plots using fixed‐ and random‐effects models implemented via the netmeta and gemtc R packages. Key Results We demonstrate the functionality of NetMetaEasy using a real‐world pharmacological dataset evaluating the cardiovascular outcomes of sodium/glucose cotransporter 2 (SGLT2) inhibitors. The platform successfully generated all standard NMA outputs, identified treatments with statistically significant benefits over placebo and showed no evidence of small‐study bias. The entire workflow, from data upload to interpretation‐ready plots,was completed within minutes. The registration‐free NetMetaEasy analysis platform is accessible at http://www.metaanalysisonline.com/netmetaeasy . Conclusion and Implications NetMetaEasy provides an accessible solution for conducting network meta‐analyses by streamlining data processing, analysis and visualization into a single online interface, thereby enabling more widespread and rapid evidence synthesis in pharmacology, particularly for researchers without formal statistical training.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Bioinformatics, Semmelweis University, Budapest, Hungary.
- Institute of Transdisciplinary Discoveries, Medical School, University of Pecs, Pecs, Hungary.
- Heart Institute, Medical School, University of Pecs, Pecs, Hungary.
- HUN-REN Research Centre for Natural Sciences, Institute of Molecular Life Sciences, Budapest, Hungary.
ORCID profiles: Balázs Győrffy
Cite
APA
Fekete, J. T., Komócsi, A., & Győrffy, B. (2026). NetMetaEasy: enabling rapid and user‐friendly network meta‐analysis (NMA) for comparative effectiveness research. British Journal of Pharmacology, 183(9), 1814-1823. https://doi.org/10.1111/bph.70391
Vancouver
Fekete JT, Komócsi A, Győrffy B. NetMetaEasy: enabling rapid and user‐friendly network meta‐analysis (NMA) for comparative effectiveness research. British Journal of Pharmacology. 2026;183(9):1814-1823. doi:10.1111/bph.70391
BibTeX
@article{Fekete2026,
author = {Fekete, János Tibor and Komócsi, András and Győrffy, Balázs},
title = {NetMetaEasy: enabling rapid and user‐friendly network meta‐analysis (NMA) for comparative effectiveness research},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {9},
pages = {1814--1823},
doi = {10.1111/bph.70391}
}
EUVIMED